Echinacea (E. angustifolia DC, E. pallida, E. purpurea)

 

Contents of this page:
 

 

Echinacea
Echinacea

Background

Echinacea species are perennials which belong to the Aster family and which originate in eastern North America. Traditionally used for a range of infections and malignancies, the roots and herb (above ground parts) of echinacea species have attracted recent scientific interest due to purported "immune stimulant" properties. Oral preparations are popular in Europe and the United States for prevention and treatment of upper respiratory tract infections (URI), and  Echinacea purpurea  herb is believed to be the most potent echinacea species for this indication. In the U.S., sales of echinacea are believed to represent approximately 10% of the dietary supplement market.

 

For URI treatment, numerous human trials have found echinacea to reduce duration and severity, particularly when initiated at the earliest onset of symptoms. However, the majority of trials, largely conducted in Europe, have been small or of weak design. Negative results exist of a U.S. trial in adults, which used a whole-plant echinacea preparation containing both  E. purpurea  and  E. angustifolia . Another clinical trial reported in July 2005 did not demonstrate any clinical benefit either. However, a 2006 meta-analysis investigating the efficacy of echinacea found that the likelihood of experiencing a clinical cold was 55% higher with placebo than with Echinacea (based on three trials). The sum of the current is conflicting and further well-designed studies are needed before a definitive conclusion can be drawn. Lack of benefit in children ages 2-11 has also been reported.

 

For URI  prevention  (prophylaxis), daily echinacea has not been shown effective in human trials.

 

Preliminary studies of echinacea taken by mouth for genital herpes and radiation-associated toxicity remain inconclusive. Topical  E. purpurea  juice has been suggested for skin and oral wound healing, and oral/injectable echinacea for vaginal  Candida albicans  infections, but evidence is lacking in these areas.

 

The German Commission E discourages use of echinacea in patients with autoimmune diseases, but this warning is based on theoretical considerations rather than human data.

 

Synonyms

American coneflower, black Sampson, black Susan, cock-up-hat, combflower, Echinacin®, Echinaforce®, Echinaguard®, hedgehog, igelkopf, Indian head, Kansas snake root, kegelblume, narrow-leaved purple coneflower, purple coneflower, red sunflower, rudbeckia, scurvy root, snakeroot, solhat, sun hat.

 

Evidence

These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Uses based on scientific evidence Grade*
Cancer

There is no clear human evidence of the effects of echinacea on any type of cancer.

C
Immune system stimulation

Echinacea has been studied alone and in combination preparations for immune system stimulation (including in patients receiving cancer chemotherapy). It remains unclear if there are clinically significant benefits. Additional studies are needed in this area before conclusions can be drawn regarding safety or effectiveness.

C
Low white blood cell counts after X-ray treatment

Studies have reported mixed results, and it is not clear whether echinacea has benefits for this use.

C
Prevention of upper respiratory tract infections (adults and children)

Preliminary studies suggest that echinacea is not helpful for preventing the common cold in adults. A recent meta-analysis suggested that standardized extracts of echinacea were effective in the prevention of symptoms of the common cold after clinical inoculation, compared with placebo. In children, a combination of echinacea, propolis, and vitamin C has been reported to reduce the number and duration of cold episodes. However, prevention research overall has not been well designed, and additional trials are needed before a clear conclusion can be drawn.

C
Treatment of upper respiratory tract infections (adults)

Although multiple low quality studies have previously suggested that taking echinacea by mouth by adults when cold symptoms begin may reduce the length and severity of symptoms, a clinical trial reported in July 2005 did not demonstrate any clinical benefit. Recent meta-analyses are conflicting; one suggested that standardized extracts of echinacea were effective in the prevention of symptoms of the common cold after clinical inoculation, compared with placebo, whereas the other reported no such benefit. Further research is needed.

C
Genital herpes

Initial human studies suggest that echinacea is not helpful in the treatment of genital herpes.

D
Treatment of upper respiratory tract infections (children)

Initial research suggests that echinacea may not be helpful in children for alleviation of cold symptoms, possibly because parents are not able to recognize the onset of common cold symptoms soon enough to begin treatment, or because the dose of echinacea for use in children is not clear. There are fundamental differences in causes of upper respiratory tract infection symptoms in children versus adults (bacterial versus viral causes; different viruses; different sites of infection; etc). Until additional research is available, echinacea cannot be considered effective in children for this use. Furthermore, development of rash has been associated with echinacea use, and therefore the risks may outweigh the potential benefits in this population.

D

 

*Key to grades
A: Strong scientific evidence for this use;
B: Good scientific evidence for this use;
C: Unclear scientific evidence for this use;
D: Fair scientific evidence against this use;
F: Strong scientific evidence against this use.

 

Grading rationale

Uses based on tradition or theory
The below uses are based on tradition or scientific theories. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Abscesses, acne, attention deficit hyperactivity disorder (ADHD), bacterial infections, bee stings, boils, burn wounds, cold sores, diphtheria, dizziness, eczema, gingivitis, hemorrhoids, HIV/AIDS, malaria, menopause, migraine headache, nasal congestion/runny nose, pain, psoriasis, rheumatism, skin ulcers, snake bites, stomach upset, syphilis, tonsillitis, typhoid, urinary tract infections, whooping cough (pertussis), yeast infections.

Dosing

The below doses are based on scientific research, publications, traditional use, or expert opinion. Many herbs and supplements have not been thoroughly tested, and safety and effectiveness may not be proven. Brands may be made differently, with variable ingredients, even within the same brand. The below doses may not apply to all products. You should read product labels, and discuss doses with a qualified healthcare provider before starting therapy.

Adults (18 years and older)
Capsules (of powdered herb): For treatment of upper respiratory tract infections, 500 to 1,000 milligrams by mouth three times daily for five to seven days has been used.

 

Expressed juice: 6 to 9 milliliters by mouth daily, divided into two or three doses, for five to seven days has been used.

 

Extract: 300 milligrams of  E. purpurea  extract by mouth three times daily, 300 milligrams of  E. angustifolia  root extract three times daily, or  E. purpurea  above-ground plant parts three times daily (176 milligrams EchinaGuard® [Echinacin®] Madaus GmbH) has been found effective in the prevention and/or treatment of colds although more research is needed to confirm these results.

 

Tincture (1:5): 0.75 to 1.5 milliliters, gargled then swallowed, two to five times daily for five to seven days has been used (daily dose equivalent to 900 milligrams dried echinacea root). Some herbalists prefer tinctures due to theoretical immune stimulation in the tonsils when tinctures are gargled before swallowing.

 

Tea: Two teaspoons of coarsely powdered herb (4 grams of echinacea) in one cup of boiling water for 10 minutes, drink daily for five to seven days, is a dose that has been used. There is early evidence that echinacea tea (equivalent of 1.275 milligrams of dried herb and root per tea bag) may reduce the symptoms of upper respiratory tract infection when 5 to 6 cups are taken on the first day and decreased by 1 cup each day for the next five days.

 

Applied to skin (semisolid preparation): 15% pressed herb (non-root) juice semisolid preparation has been applied daily for wounds and skin ulcers.

 

Injected/through the veins: Injected echinacea is not available commercially. Severe reactions to injected echinacea have been reported, and echinacea injections are not recommended.

 

Children (younger than 18 years)
The dosing and safety of echinacea have not been studied thoroughly in children. Reductions of recommended adult doses by 50-67% have been used in research without significant effects in the treatment of common cold symptoms, and an association with rash development. Parents considering echinacea for their children should discuss this decision with the child's health care provider before starting therapy. Some natural medicine practitioners recommend basing children's doses based on weight. To calculate the child's dose, they take the child's weight in pounds, divide by 150, and then multiply that number by the recommended adult dose.

 

Safety

The U.S. Food and Drug Administration does not strictly regulate herbs and supplements. There is no guarantee of strength, purity or safety of products, and effects may vary. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy. Consult a healthcare provider immediately if you experience side effects.

Allergies
People with allergies to plants in the Asteraceae or Compositae family (ragweed, chrysanthemums, marigolds, daisies) are theoretically more likely to have allergic reactions to echinacea. Multiple cases of anaphylactic shock (severe allergic reactions) and allergic rash have been reported with echinacea taken by mouth. Allergic reactions including itching, rash, wheezing, facial swelling, and anaphylaxis may occur more commonly in people with asthma or other allergies. Echinacea injections have caused severe reactions and are not recommended.

 

Echinacea has been associated with an increased incidence of rash in children, and therefore the risks of use may outweigh potential benefits.

 

Side Effects and Warnings
Few side effects from echinacea are reported when it is used at the recommended doses. Reported complaints include stomach discomfort, nausea, sore throat, rash (allergic, hives, or painful lumps called "erythema nodosum"), drowsiness, headache, dizziness, and muscle aches. Rare cases of hepatitis (liver inflammation), kidney failure, or irregular heart rate (atrial fibrillation) have been reported in people taking echinacea, although it is not clear that these were due to echinacea itself. Injected echinacea may alter blood sugar levels and cause severe reactions, and should be avoided. Echinacea has been associated with an increased incidence of rash in children, and therefore the risks of use may outweigh potential benefits. Thrombotic thrombocytopenic purpura (TTP) has also been reported.

 

Some natural medicine experts discourage the use of echinacea by people with conditions affecting the immune system, such as HIV/AIDS, some types of cancer, multiple sclerosis, tuberculosis, and rheumatologic diseases (such as rheumatoid arthritis or lupus). However, there are no specific studies or reports in this area, and the risks of echinacea use with these conditions are not clear. Long-term use of this herb may cause low white blood cell counts (leukopenia).

 

Pregnancy and Breastfeeding
At this time, echinacea cannot be recommended during pregnancy or breastfeeding. Although early studies show no effect of echinacea on pregnancy, there is not enough research in this area. Pregnant women should avoid tinctures because of the potentially high alcohol content.

 

Interactions

Most herbs and supplements have not been thoroughly tested for interactions with other herbs, supplements, drugs, or foods. The interactions listed below are based on reports in scientific publications, laboratory experiments, or traditional use. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy.

Interactions with Drugs
Natural medicine practitioners sometimes caution that echinacea may lead to liver inflammation. There is not clear information from laboratory or human studies in this area. Nonetheless, caution should be used when combining echinacea by mouth with other medications that can harm the liver. Examples of such agents include anabolic steroids, amiodarone, methotrexate, acetaminophen (Tylenol®), and antifungal medications taken by mouth (such as ketoconazole). Echinacea may affect the way certain drugs are broken down by the liver.

 

In theory, echinacea's ability to stimulate the immune system may interfere with drugs that are taken to suppress the immune system (including azathioprine, cyclosporine, and steroids such as prednisone). No clear human studies are available.

 

In one vague report, a person taking the antibiotic amoxicillin and an unclear echinacea preparation developed muscle damage, shock, and death.

 

Early information suggests that the use of echinacea with econazole nitrate cream (Spectazole®) on the skin may lower the frequency of vaginal yeast infections after treatment.

 

Many tinctures contain high levels of alcohol, and may cause nausea or vomiting when taken with metronidazole (Flagyl®) or disulfiram (Antabuse®).

 

Interactions with Herbs and Dietary Supplements
Natural medicine practitioners sometimes caution that echinacea may lead to liver inflammation. Although there is no clear information from laboratory or human studies, in theory echinacea may add to liver toxicity caused by other agents. Echinacea may affect the way certain herbs and supplements are broken down by the liver.

 

Echinacea is sometimes used in combination products that are thought to stimulate the immune system. For example, Esberitox® (PhytoPharmica, Germany) contains  Echinacea purpurea ,  Echinacea pallida , wild indigo root ( Baptisia tinctoria ), and thuja (white cedar). Echinacea may be combined with goldenseal or other herbs in some cold relief preparations. No high quality human studies have shown added benefits or interactions of these combinations.